Phase I trial of vandetanib (ZD6474, ZACTIMA) with concurrent radiation in treatment of newly diagnosed brainstem glioma.
Phase of Trial: Phase I
Latest Information Update: 12 Oct 2012
At a glance
- Drugs Vandetanib (Primary)
- Indications Glioma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 06 Oct 2011 Planned end date changed from 1 Jan 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 01 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.